References
- Talpaz M., Kantarjian H., Kurzrock R., Trujillo J. M., Gutterman J. U. Interferon-Alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome positive patients. Annals of Internal Medicine 1991; 114: 532–538
- Estro Z., Talpaz M., Chou T. C., Kurzrock R., Blake M., Gutterman J. U. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia. Leukemia 1991; 5: 101–107
- Sokal J. E., Cox E. B., Baccarani M., Tura S., Gomez G. A., Robertson J., Tso C. Y., Braun T. J., Clarkson B. D., Cerventes F., Rozman C, the Italian Cooperative CML Study Group. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood 1984; 63: 789–799
- Malinge M. C., Mahon F. X., Delfau M. H., Daheron L., Kitzis. A. Guilhot F., Tanzer J., Grandchamp B. Quantitative determination of the hybrid bcr-abl mRNA in patients with chronic myelogenous leukemia under interferon therapy. British Journal of Haematology 1992; 82: 701–-707
- Berman E., Duigou-Osterdorf R., Known S. E., Fanucchi M. P., Chou J., Hirsch M. S., Clarkson B. D., Chou T. C. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on nonnal human bone marrow progenitor cells. Blood 1989; 74: 1281–1286
- Strayer D. R., Brodsky I., Caranfa M. J., Gillespie D. H. Quantitation of RNA-dependent DNA polymerase in patients with myeloproliferative disorders. British Journal of Haematology 1982; 50: 521–530
- Robak T., Korycka A., Gora-Tybor J. The interaction of 2-chlorodeoxyadenosine (2+ CDA) and interferon-α (IFN-α) on normal and myeloid leukemia hematopoiesis in nitro. Leukemia Research 1994; 18: 275–281
- Osman Y., Moriyama Y., Shibata A. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-α, TNF, and quercetin): its application to autologous bone marrow transplantation for CML. Experimental Hematology 1995; 2: 344–452
- Gallo R. C. A surprising advance in the treatment of viral leukemia. New England Journal of Medicine 1995; 332: 1783–1785